Dana Investment Advisors, Inc. Catalent, Inc. Transaction History

Dana Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$45.44 - $74.26 $50,756 - $82,948	-1,117 Reduced 12.27%	7,984 $524,000
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $87,788 - $171,801	2,121 Added 30.39%	9,101 $409,000
Q3 2022 Nov 15, 2022	BUY	$72.36 - $113.1 $39,508 - $61,752	546 Added 8.49%	6,980 $505,000
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $561,044 - $733,797	6,434 New	6,434 $690,000

319

114M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.